High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic LeukemiaStephan Müller, Evelyn Ullrich, Winfried S. Wels et al.|Frontiers in Immunology|2020Cited by 111
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectorsTobias Bexte, Evelyn Ullrich, Lacramioara Botezatu et al.|Molecular Therapy|2024Cited by 44
Non-Viral <i>Sleeping Beauty</i> Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic EfficiencyTobias Bexte, Evelyn Ullrich, Lacramioara Botezatu et al.|Blood|2021Cited by 14
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapyLisa Marie Reindl, Evelyn Ullrich, Lida Jalili et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8